Cherilyn buys RCPT 40.43: Receptos Announces Proposed Underwritten Public Offering of Common Stock
Receptos, Inc. (NASDAQ:RCPT) , a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, announced today that it intends to offer shares of its common stock in an underwritten public offering. ...
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home